Patent 9242044 was granted and assigned to Novo Nordisk on January, 2016 by the United States Patent and Trademark Office.
An automatic injection device (100) adapted to automatically eject a dose of a medicament by automatically inserting a needle (112) into the skin of a user, ejecting a dose of a medicament through the needle, and subsequently retracting the needle into a housing (122) of the device.